MS sufferers losing hope for Manitoba trials
Winnipeg Free Press
Winnipeg journalist Ingeborg Boyens received MS liberation therapy in New York. She's doubtful it will get clinical trials in Manitoba. Saskatchewan has abandoned homegrown clinical trials meant to test a new multiple sclerosis therapy, and MS ...
See all stories on this topic »

Exciting Research Connects Epstein-Barr to MS Brain Lesions & Potentially ...
ProHealth
A new study by researchers at Queen Mary, University of London shows how the Epstein-Barr virus tricks the immune system into triggering an acute inflammatory process and nerve cell damage in the brain, which is known to cause MS. ...
See all stories on this topic »

Three Novel Multiple Sclerosis Susceptibility Loci Identified
Doctors Lounge
Three novel multiple sclerosis genetic susceptibility loci have been identified, according to a meta-analysis published in the December issue of the Annals of Neurology. FRIDAY, Jan. 6 (HealthDay News) -- Three novel multiple sclerosis (MS) genetic ...
See all stories on this topic »

Stamford MS Support Group
ShorelinePlus.com
The Stamford MS Support Group meets from 7 to 8:30 pm on the second and fourth Thursday of each month at St. Camillus Heath Center at 494 Elm St., in Stamford, Conn. There are more than 6000 Connecticut residents diagnosed with multiple sclerosis (MS), ...
See all stories on this topic »

Hopes for Reversing Age-Associated Effects in MS Patients
Science Daily (press release)
6, 2012) — New research highlights the possibility of reversing ageing in the central nervous system for multiple sclerosis (MS) patients. The study is published on January 6, in the journal Cell Stem Cell. As we get older, our bodies' ability to ...
See all stories on this topic »

Questcor: Acthar Prescriptions Rose 165% In 4Q
Wall Street Journal (India)
Questcor Pharmaceutical Inc. (QCOR) said the number of paid prescriptions of its treatment for the flare-up of multiple sclerosis more than doubled in the fourth quarter from a year earlier. Shares rose 3.5% to $40.30 in after-hours trading as the ...
See all stories on this topic »